Core Viewpoint - Domestic beauty brands are gaining competitive advantages in the market through high cost-performance ratios and refined operations [1][7]. Group 1: Market Performance - In early 2024, the retail sales of cosmetics in China are projected to be 435.7 billion yuan, a year-on-year decline of 1.1% [2]. - Despite the overall market stagnation, several domestic beauty companies have reported impressive performance, with Proya (603605.SH) achieving a revenue of 10.778 billion yuan, a year-on-year increase of 21.04% [2][3]. - Other established beauty companies such as Shiseido (02145.HK), Maogeping (01318.HK), and Marubi (603983.SH) also reported revenue growth exceeding 20% [2]. Group 2: Online Sales Strategy - Leading beauty companies are increasingly focusing on online sales, with Proya's online sales ratio exceeding 95% and sales surpassing 10 billion yuan [4]. - Shiseido's online sales ratio is over 90%, with sales exceeding 6 billion yuan, while Marubi's online sales ratio is above 85% [4]. - In the e-commerce landscape, Douyin has emerged as a significant player, with total beauty sales reaching between 2.5 billion to 5 billion units and total sales exceeding 100 billion yuan [4]. Group 3: Quarterly Performance - In Q1 2025, the retail sales of cosmetics reached 114.9 billion yuan, a year-on-year increase of 3.2% [6]. - Proya reported a Q1 2025 revenue of 2.359 billion yuan, up 8.13% year-on-year, and a net profit of 390 million yuan, up 28.87% [6]. - Marubi achieved a Q1 2025 revenue of 847 million yuan, a year-on-year increase of 28.01%, with a net profit of 135 million yuan, up 22.07% [6]. Group 4: Future Outlook - The management of Juzhi Biological aims for a revenue growth of 25% to 28% and a net profit growth of 21% to 24% for the 2025 fiscal year [7]. - The cosmetics and medical beauty industry is expected to show stable growth driven by policy support and consumer recovery [7]. - Domestic beauty brands are focusing on reducing traffic costs and enhancing digital marketing strategies to ensure measurable business growth [7].

以下文章来源于财经天下WEEKLY ，作者财经天下 财经天下WEEKLY . 《财经天下》周刊官方账号，提供有品质的深度报道，讲述中国企业在时代浪潮中的精彩故事。 来源丨财经天下WEEKLY（ID：cjtxweekly） 作者丨林木 编辑丨吴跃 图源丨Midjourney 因为陷入"EGF（表皮生长因子）罗生门"，可复美近期被推上风口浪尖。 不久前，有消费者反映可复美产品"违规添加EGF"。随后可复美母公司巨子生物予以否认，称"旗下所有 产品均未添加"。伴随着舆论发酵，社媒平台上，看客们吵得沸沸扬扬，力挺声、质疑声四起，也让"可 复美"这个名字被更多人知晓。 做过医美或者皮肤敏感的消费者，大多对"可复美"三个字不陌生。这个主打皮肤修复的品牌，早年间主 要深耕院线渠道，之后乘上直播电商风口，进入更多人视野，撬开更多钱包。过去6年，其母公司巨子生 物营收从9.57亿元涨至55.39亿元，翻了5倍多。 2024年，巨子生物一举超越珀莱雅，成为市值最高的国货美妆公司，此后一直保持至今。公司创始人， 现年59岁的陕西人范代娣，也因此登顶国货美妆首富。 95后女生冯琳第一次知道"可复美"，是被皮肤敏感的姐姐种草的。202 ...

港股消费爆发。 作者 I 杨继云 报道 I 投资界PEdaily 那是3月5日这天，老铺黄金以600港元/股的价格超越腾讯，成为港股新一任"股王"。没 有人会想到这一幕：老铺黄金自去年6月上市，此后股价一路飞涨，至今涨幅已经超过2 0 倍。 "爆赚，准备原地退休了"。早早上车的人难掩喜悦，这样的分享帖子遍布社交媒体。身 边消费投资人则拍断了大腿： "当初没有投进去。" 这是港股消费公司的一缕缩影。如你所见，资本市场对蜜雪冰城、泡泡玛特报以同样热情 ——他们都涨幅惊人。至此， 泡泡玛特、蜜雪冰城、老铺黄金一起组成了"港股三姐妹" 。 "现在有合适的消费公司赶紧推去港股。"目睹几家消费公司的罕见暴涨，一位头部VC投 资人如是喊话。嘉御资本创始合伙人兼董事长卫哲则向投资界分享他的一个观点："中国 资产重估始于港股，港股重估始于消费公司"。 三姐妹崛起 港股三家千亿消费公司 港股三姐妹，今年密集地出现在投资人聊天之间。 老铺黄金，始于湖南岳阳人徐高明——他于200 4年进军消费级黄金产品市场，后来在北 京创办老铺黄金。他将黄金从"克重计价"的实用主义中剥离，把黄金卖成奢侈品，万元 以上的产品贡献了近9 0%营收，由此 ...

Group 1 - The Hang Seng Medical Index ETF experienced a turnover of 8.47% during the trading session, with a transaction volume of 21.38 million yuan [3] - The ETF's scale increased by 18.48 million yuan over the past week, indicating significant growth [3] - The ETF's shares grew by 10 million shares this month, reflecting substantial growth [3] Group 2 - The current price-to-earnings ratio (PE-TTM) of the Hang Seng Medical Index ETF is 24.86, which is at a historical low, being in the 6.5% percentile over the past year [3] - A joint implementation plan for the digital transformation of the pharmaceutical industry has been issued by seven government departments, aiming for significant progress by 2027 [3] Group 3 - Short-term AI medical themes are expected to continue being a focus, with market attention shifting towards Q1 performance and potential improvements in the pharmaceutical industry by Q2 2025 [4] - The top ten weighted stocks in the Hang Seng Medical Index account for 57.69% of the index, including companies like BeiGene, WuXi Biologics, and JD Health [4] - Investors without stock accounts can access the Hang Seng Medical Index ETF through a linked fund for investment opportunities in the Hong Kong medical sector [4]

重组胶原蛋白行业在技术、工艺上持续进步，继I型、III型后在XVII型、IV型以及多型别组合方面再现突破；各龙头公司在结构解析、发酵制 备、产品化、商业化方面的闭环能力更为成熟。格局方面，各公司均综合布局"妆&二类械&消费/严肃医疗三类械"，同时又在各自擅长的品类深 耕，差异化竞争。最后，中国重组胶原蛋白全球化提速，"原料、妆、械"全面出海。 ▍ 皮肤具备多种生理功能，胶原蛋白分布广且功效多样。 皮肤呈现层叠结构，由表皮、真皮、皮下组织构成。皮肤具有屏障、吸收、分泌和排泄、感觉、体温调节、物质代谢、免疫等多种功能，直接 参与全身的各种功能活动并维持内环境的稳定。人体内2 9种型别胶原蛋白，各型别功能和分布有所区别。目前人类研究发现的胶原蛋白共2 9 种，当前市场上开发和商业化较多的为I型和III型胶原蛋白。双光子显微成像等技术能够有效检验重组胶原蛋白透皮吸收情况。 文 ｜ 徐晓芳 杜一帆 张琳 宋硕 徐嘉琪 皮肤生理功能梳理 | 序号 功能 | | 功能解析 | | --- | --- | --- | | 1 | 屏障功能 | 一方面,保护机体内各种器官组织免受外界环境中机械的、物理的、化学的和生物 | | ...

Group 1 - The Hong Kong stock market rebounded last week amid the easing of tensions from the Trump tariff war, but market sentiment remains cautious due to numerous uncertainties [1] - Major tech companies in the US, including Apple, Microsoft, Amazon, and Meta, are set to release their earnings reports this week, with a focus on performance and supply chain conditions [2] - The upcoming May Day holiday may set the tone for market trends, with technology and domestic demand stimulation expected to be key focus areas [3] Group 2 - The Chinese government has approved nuclear power projects, including the Zhejiang Sanmen Phase III project, indicating ongoing investment in nuclear energy [4] - The surgical robot company MicroPort has seen significant growth potential, with domestic installations expected to accelerate due to regulatory changes and increased clinical recognition [5] - The collaboration between Honghu and MicroPort in overseas markets is anticipated to enhance growth, with a notable increase in their transaction limits for related business [6] Group 3 - The personal care sector is experiencing significant growth driven by product innovation and new distribution channels, with companies like Ruyuchen and Dengkang Oral achieving substantial revenue increases [7] - The beauty sector is also thriving, with companies like Jizi Biotechnology and Marumi Biotech reporting impressive revenue growth, indicating a shift in consumer preferences towards innovative products [7] - The medical aesthetics market is witnessing new opportunities with the approval of new products, suggesting a robust growth trajectory for companies in this space [7] Group 4 - The Hong Kong stock market is advised to focus on companies like Maogeping and Juzibio, which are positioned for growth in their respective sectors [8] - The Hang Seng Index is currently stable, with a significant number of open contracts indicating a cautious outlook amid external uncertainties [9] - Analysts remain optimistic about the relative performance of Hong Kong stocks, particularly in sectors sensitive to tariffs and those benefiting from domestic demand policies [12]

Summary of Key Points from the Conference Call Industry or Company Involved - The conference call primarily discusses the Chinese economy, focusing on various sectors including real estate, infrastructure, consumer services, and the impact of external trade policies. Core Insights and Arguments 1. **Economic Growth and Risk Management**: The Political Bureau meeting emphasized the dual focus on stabilizing growth and managing risks, indicating a stronger policy response to economic challenges, particularly in service consumption and support for foreign trade enterprises [1][2][3]. 2. **Real Estate Strategy**: The meeting highlighted the importance of real estate, proposing a new development model that includes increasing the supply of high-quality housing and optimizing land acquisition policies to stabilize the market [1][19][20]. 3. **Infrastructure Investment**: Government investment is seen as a key driver, with a focus on major projects in economically advantageous regions like the Yangtze River Delta and Greater Bay Area, as well as significant projects in western regions [1][28][29]. 4. **Service Consumption Growth**: There is a strong signal to boost income for low- and middle-income groups and develop service consumption, with expectations that service retail will account for over 40% of total retail sales by 2027 [1][37][41]. 5. **Impact of Tariffs on Textile and Apparel**: Chinese textile and apparel companies are adapting to U.S. tariff policies by relocating production to Southeast Asia, while maintaining competitiveness through price adjustments [1][42][44]. 6. **Cross-Border E-commerce**: The cross-border e-commerce market is thriving despite tariff challenges, with companies like Dunhuang.com performing well in the U.S. market [1][43]. 7. **AI and Technology in Retail**: The integration of AI technology is transforming the retail landscape, with major Chinese internet companies investing heavily in AI infrastructure and applications [1][50][51]. Other Important but Potentially Overlooked Content 1. **Challenges in Land Acquisition**: The government faces challenges in land acquisition policies, including pricing and funding issues, which may hinder the execution of real estate strategies [1][22][23]. 2. **Slow Progress in Urban Village Renovation**: Urban village renovation has been slow, with various obstacles such as funding models and compensation mechanisms affecting progress [1][24]. 3. **Consumer Behavior Trends**: New consumption trends are emerging, with a focus on personalized and unique experiences driving growth in sectors like beauty care and personal grooming [1][48][49]. 4. **Investment Opportunities in Infrastructure**: The emphasis on urban renewal and infrastructure investment presents significant opportunities for growth in the construction and related sectors [1][31][32]. 5. **Potential for High-Quality Housing**: The trend towards high-quality housing is gaining momentum, with local governments implementing new standards to enhance living conditions [1][21][25]. This summary encapsulates the key points discussed in the conference call, providing insights into the current economic landscape and potential investment opportunities within various sectors.

以下文章来源于财经天下WEEKLY ，作者财经天下 财经天下WEEKLY . 《财经天下》周刊官方账号，提供有品质的深度报道，讲述中国企业在时代浪潮中的精彩故事。 毛利率在80%以上，研发投入却较低。 作者：林木 编辑：吴跃 来源：财经天下WEEKLY 因为陷入"EGF（表皮生长因子）罗生门"，可复美近期被推上风口浪尖。 不久前，有消费者反映可复美产品"违规添加EGF"。随后可复美母公司巨子生物予以否认， 称"旗下所有产品均未添加"。伴随着舆论发酵，社媒平台上，看客们吵得沸沸扬扬，力挺声、 质疑声四起，也让"可复美"这个名字被更多人知晓。 做过医美或者皮肤敏感的消费者，大多对"可复美"三个字不陌生。这个主打皮肤修复的品牌， 早年间主要深耕院线渠道，之后乘上直播电商风口，进入更多人视野，撬开更多钱包。过去6 年，其母公司巨子生物营收从9.57亿元涨至55.39亿元，翻了5倍多。 2024年，巨子生物一举超越珀莱雅，成为市值最高的国货美妆公司，此后一直保持至今。公 司创始人，现年59岁的陕西人范代娣，也因此登顶国货美妆首富。 爱美的女生，这些年托举过不少美妆公司。当下风头最盛的可复美和巨子生物，到底是何来 头？为 ...

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The retail sector is experiencing a rise in emotional consumption trends, with leading retail companies actively transforming through quality retail, cross-border trendy play, and co-branding with fashion IPs, which is expected to lead to performance recovery and valuation revaluation in the long term [4][30] - The report highlights the ongoing disclosure of annual and quarterly reports, indicating that high-quality companies in high-prosperity sectors are worth monitoring [4][27] - The retail index has shown a slight increase of 0.07% recently, but has decreased by 5.00% since the beginning of 2025, underperforming the broader market [6][15] Summary by Sections Retail Market Review - The retail index closed at 2127.02 points, with a weekly increase of 0.07%, ranking 24th among 31 primary industries [6][15] - The supermarket sector showed the largest increase this week, while the watch and jewelry sector has led the gains since the beginning of 2025 [18][21] Retail Insights: Focus on Beauty Care, Gold Jewelry, and Traditional Retail - The report emphasizes the performance divergence among companies in the cosmetics, medical beauty, gold jewelry, and traditional retail sectors, with a positive outlook for quality companies in the retail sector due to the recovery of consumer demand [27][30] - Key companies such as Yonghui Supermarket and Aiying Room are highlighted for their proactive transformation and potential for performance recovery [41][42] Key Company Performances - Proya achieved a 28.9% increase in net profit in Q1 2025, supported by a series of new product launches [47] - Yonghui Supermarket reported a revenue of 174.79 billion yuan in Q1 2025, down 19.3% year-on-year, but is undergoing significant store renovations [30][46] - The report suggests focusing on companies with strong growth potential in high-prosperity segments, including Proya, Aiying Room, and gold jewelry brands like Laopu Gold and Chaohongji [44][42]

Core Viewpoint - Guangdong Marubi Biotechnology Co., Ltd. reported a strong performance for 2024, with revenue reaching 2.97 billion RMB, a year-on-year increase of 33.44%, and net profit attributable to shareholders rising by 31.69% to 341.63 million RMB [1][3]. Financial Performance - Revenue for 2024 was 2,969,770,566.54 RMB, up from 2,225,594,089.54 RMB in 2023, marking a 33.44% increase [3]. - Net profit attributable to shareholders was 341,628,707.73 RMB, compared to 259,417,875.91 RMB in 2023, reflecting a 31.69% growth [3]. - The main brand, Marubi, achieved over 2 billion RMB in revenue, while the PL Lover brand approached 1 billion RMB [6][8]. Business Segments - Skincare remains the top revenue category, generating 2.4 billion RMB, while the eye care segment has dropped to the third position [18]. - The PL Lover brand saw a revenue increase of 40.72%, reaching 905 million RMB, marking a staggering growth of approximately 1271 times since 2019 [11][12]. Market Position and Strategy - Marubi has successfully transitioned from a three-year growth stagnation post-IPO to a robust growth phase, driven by the restructuring of collagen technology and dual-brand development [6][7]. - The company has focused on a big product strategy, with significant sales from key products like the peptide eye cream and collagen essence [17][20]. Sales Channels and Regional Performance - Online sales accounted for 2.54 billion RMB, a 35.77% increase, while offline sales rose by 20.79% to 427 million RMB [20]. - The South China region generated 2.16 billion RMB in revenue, a 41.06% increase, while the Northeast region experienced the fastest growth at 63.30% [21][22]. Competitive Landscape - Despite the positive financial results, Marubi lags behind competitors like Proya and Up Beauty in terms of revenue and brand scale, with a significant gap to close [24][25]. - The company's R&D investment was 74 million RMB, ranking second to last among the top 10 beauty companies, raising concerns about its long-term competitiveness [25][27].